Press Releases
KSI & RFIDeas Introduce an Integrated Solution for ePrescribe
RFIDeas the innovator of WaveID® and KSI Inc. will introduce the first compliant ePrescribe keyboard for controlled substances at this year's HIMSS Annual...
Press Releases
Novozymes Biopharma’s rAlbumin approved in Japan as MAQUET expands into new market
Novozymes Biopharma, part of Novozymes A/S, a world leader in bioinnovation, has announced that one of its leading customers has achieved approval of...
Clinical Trials
Boston Therapeutics presents PAZ320 drug positive Phase ll results
Boston Therapeutics has presented positive results of its PAZ320 drug, designed for reducing post-meal elevation of blood glucose, from its Phase ll clinical...
Clinical Trials
Avaxia treats first patient in ulcerative colitis drug study
Avaxia Biologics has treated the first patient in a Phase1b clinical study using AVX drug dosage, designed for the treatment of ulcerative colitis....
Press Releases
Promethera Biosciences opens the French part of its clinical trial in cell therapy
Promethera Biosciences, a Belgian biotechnology company developing Promethera(R) HepaStem, a cell-based therapy for the treatment of liver-based metabolic diseases including Crigler-Najjar Syndrome and...
Press Releases
Trophos announces positive interim review in pivotal study of olesoxime in Spinal Muscular Atrophy
Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for under-served medical needs in neurology and cardiology,...
Production & Manufacturing
Qualicaps to invest $26m for Whitsett facility expansion
Pharmaceutical manufacturer Qualicaps will invest $26m to expand its facility in Whitsett, North Carolina in the US. Under the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read